H. Zilch

发表

Non-nucleoside inhibitors of HIV-1 reverse transcriptase: molecular modeling and X-ray structure investigations.

W. Schäfer, W. G. Friebe, H. Leinert, 1993, Journal of medicinal chemistry.

Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes.

H. Boddeke, J. Christophe, C. Strohmann, 1989, European journal of pharmacology.

Enantioselective reduction of acetyldimethylphenylsilane by Trigonopsis variabilis (DSM 70714)

C. Syldatk, H. Zilch, B. Stumpf, 1987, Applied Microbiology and Biotechnology.

Sila-substitution--a useful strategy for drug design?

H. Zilch, R. Tacke, 1986, Endeavour.

Selective non-nucleoside HIV-1 reverse transcriptase inhibitors. New 2,3-dihydrothiazolo[2,3-a]isoindol-5(9bH)-ones and related compounds with anti-HIV-1 activity.

W. Schäfer, H. Leinert, A. Mertens, 1993, Journal of medicinal chemistry.

Enantioselective microbial reduction of 1,1-dimethyl-1-sila-cyclohexan-2-one with growing cells of the yeast Kloeckera corticis (ATCC 20109)

H. Zilch, B. Stumpf, R. Tacke, 1989 .

Binding and functional properties of antimuscarinics of the hexocyclium/sila‐hexocyclium and hexahydro‐diphenidol/hexahydro‐sila‐diphenidol type to muscarinic receptor subtypes

J. Christophe, C. Strohmann, H. Zilch, 1989, British journal of pharmacology.

A study of the bile pigments and related compounds in solution by 13C nuclear magnetic resonance spectroscopy

V. Wray, H. Zilch, A. Gossauer, 1979 .

Biosynthesis of vitamin B12. Concerning the mechanism of the uro'gen III → cobyrinic acid transformation

J. Engel, E. Neumann, M. Kajiwara, 1977 .